Analystreport

Seres Therapeutics, Inc. (NASDAQ: MCRB) had its price target lowered by analysts at Piper Sandler from $32.00 to $7.00.

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com